MENU
ACGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aceragen (ACGN) Ownership - Who owns Aceragen?

Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
505 Eagleview Boulevard
Phone
+1 484 348-1600
Employees
26
Web
https://www.aceragen.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.2M
P/E Ratio
N/A
Total Cash
4.68M
Projected Growth
N/A
Total Debt
625K
Revenue
49K
Risk (Beta)
0.05
Dividend Yield
N/A
Total Cash/Share
0.56
Total Debt/Equity
N/A
Revenue/Share
1.12 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of novel nucleic acid therapeutics

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
505 Eagleview Boulevard
Phone
+1 484 348-1600
Employees
26
Web
https://www.aceragen.com
Who owns Aceragen? ACGN symbol Ownership - Tickeron.com